StockData
Sotera Health Co logo

Sotera Health Co (SHC) stock

SHCNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$16.25−0.36 (-2.17%)

Close on Nov 16, 2026Market cap $4.64BP/E 28.5Yield –

Earnings

Sotera Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 23, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$324.89M
+4.5% on a year earlier
Adjusted EPS, Q3 FY2026
$0.29
$0.26 a year earlier
Latest guidance
Raised
Nov 3, 2026 · 7 items

Quarterly results

Revenue and earnings per share from each of Sotera Health's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 23, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 3, 2026before the open$324.89M+4.5%$0.20$0.29Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026before the open$321.38M+9.3%$0.19$0.26Release
Q1 FY2026ended Mar 31, 2026May 5, 2026before the open$280.05M+9.8%$0.09$0.18Release
Q4 FY2025ended Dec 31, 2025Feb 24, 2026before the open$303.00M+4.5%$0.12$0.26Release
Q3 FY2025ended Sep 30, 2025Nov 4, 2025before the open$311.00M+9.1%$0.17$0.26Release
Q2 FY2025ended Jun 30, 2025Aug 8, 2025before the open$294.00M+6.1%$0.03$0.20Release
Q1 FY2025ended Mar 31, 2025May 1, 2025before the open$255.00M+2.8%-$0.05$0.14Release
Q4 FY2024ended Dec 31, 2024Feb 27, 2025before the open$290.00M-6.5%$0.04$0.21Release
Q3 FY2024ended Sep 30, 2024Nov 5, 2024before the open$285.00M+8.4%$0.06$0.17Release
Q2 FY2024ended Jun 30, 2024Aug 5, 2024before the open$277.00M+8.6%$0.03$0.19Release
Q1 FY2024ended Mar 31, 2024May 2, 2024before the open$248.00M+12.2%$0.02$0.13Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Sotera Health's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
constant currency growthnon-GAAPFY2026+5.25% – +6.75%–NewAug 6, 2026
Net revenuesGAAPFY2026$1.23B – $1.25B$1.23B – $1.25BLoweredNov 3, 2026
Net revenuesFY2026$1.24B – $1.25B$1.23B – $1.25BRaisedAug 6, 2026
Adjusted EBITDAnon-GAAPFY2026$632.00M – $641.00M$632.00M – $641.00MReaffirmedNov 3, 2026
Adjusted EBITDAnon-GAAPFY2026$634.00M – $643.00M$632.00M – $641.00MRaisedAug 6, 2026
Adjusted EBITDA constant currency growthnon-GAAPFY2026+5.75% – +7.25%–NewAug 6, 2026
Adjusted EPSnon-GAAPFY2026$0.95 – $1.01$0.93 – $1.01RaisedNov 3, 2026
Adjusted EPSnon-GAAPFY2026$0.95 – $1.01$0.93 – $1.01RaisedAug 6, 2026
Capital expendituresGAAPFY2026$200.00M – $225.00M$175.00M – $225.00MRaisedNov 3, 2026
Capital expendituresFY2026$200.00M – $225.00M$175.00M – $225.00MRaisedAug 6, 2026
A weighted-average fully diluted share countGAAPFY2026289 – 291–ReaffirmedNov 3, 2026
Interest expenseGAAPFY2026$137.00M – $140.00M$135.00M – $145.00MNarrowedNov 3, 2026
Interest expenseFY2026$135.00M – $142.00M$135.00M – $145.00MLoweredAug 6, 2026
Tax rate applicable to Adjusted Net Incomenon-GAAPFY202627% – 28%27% – 29%LoweredNov 3, 2026
Tax rate applicable to Adjusted Net Incomenon-GAAPFY202627% – 28%27% – 29%LoweredAug 6, 2026
weighted-average fully diluted share countFY2026289 – 291289 – 291ReaffirmedAug 6, 2026
weighted-average fully diluted share countGAAPFY2026289 – 291–NewFeb 24, 2026

Guidance vs results

The last range Sotera Health gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Adjusted EPS$0.81 – $0.86$0.86Σ4QWithin range
FY2025Revenue$1.16B$1.16BΣ4QAbove range
FY2025Revenue growth+5.5%+5.73%Σ4QAbove range

Guidance history

Every forecast Sotera Health put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 3, 2026Capital expendituresFY2026$200.00M – $225.00MRaised
Nov 3, 2026Adjusted EBITDAFY2026$632.00M – $641.00MReaffirmed
Nov 3, 2026Adjusted EPSFY2026$0.95 – $1.01Raised
Nov 3, 2026A weighted-average fully diluted share countFY2026289 – 291Reaffirmed
Nov 3, 2026Tax rate applicable to Adjusted Net IncomeFY202627% – 28%Lowered
Nov 3, 2026Interest expenseFY2026$137.00M – $140.00MNarrowed
Nov 3, 2026Net revenuesFY2026$1.23B – $1.25BLowered
Aug 6, 2026Capital expendituresFY2026$200.00M – $225.00MRaised
Aug 6, 2026Adjusted EBITDA constant currency growthFY2026+5.75% – +7.25%New
Aug 6, 2026Adjusted EBITDAFY2026$634.00M – $643.00MRaised
Aug 6, 2026Adjusted EPSFY2026$0.95 – $1.01Raised
Aug 6, 2026weighted-average fully diluted share countFY2026289 – 291Reaffirmed
Aug 6, 2026Tax rate applicable to Adjusted Net IncomeFY202627% – 28%Lowered
Aug 6, 2026Interest expenseFY2026$135.00M – $142.00MLowered
Aug 6, 2026constant currency growthFY2026+5.25% – +6.75%New
Aug 6, 2026Net revenuesFY2026$1.24B – $1.25BRaised
May 5, 2026Capital expendituresFY2026$175.00M – $225.00MNew
May 5, 2026Adjusted EBITDAFY2026$632.00M – $641.00MNew
May 5, 2026Adjusted EPSFY2026$0.93 – $1.01New
May 5, 2026weighted-average fully diluted share countFY2026289 – 291New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Sotera Health filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Results
  7. Results
  8. Results
  9. Results
  10. Results
  11. News
  12. Update
  13. Results
  14. Results
  15. Update

See a number that looks wrong?